Entrepreneurs

How does an organization like TDS Telecom build a culture of innovation, and therefore encourage process improvements? We asked new CEO Dave Wittwer for the answer, and he noted that it's part of a reorganization where employees understand that process improvement is part of their...

Before too much of the New Year passes, DEMO Letter columnist Chris Shipley wanted to share some additional reader predictions for 2007 and beyond. These forecasts pertain to business intelligence, which could be shaken more than stirred in the forthcoming years. ...

Corporate officers and directors have been found personally liable for IP infringement if they intentionally, actively, and knowingly assist in the corporation's infringement. To minimize those risks, Madison attorney Gina Carter, in this inaugural edition of IP Law, explains the circumstances and scenarios that lead...

The French hybrid-battery unit of Johnson Controls has entered a contract to develop a plug-in, lithium-ion battery that can be recharged from a standard household electrical outlet. The plug-in will be developed for a Saturn hybrid vehicle manufactured by General Motors. ...

Compatibility issues and required computer upgrades will make adoption of the new Microsoft Windows Vista enterprise operating system a "slow go" in 2007 and perhaps even 2008, according to Wisconsin technology officers. While the system has its strengths, they advise IT departments to watch...

Third Wave Technologies has applied for Food and Drug Administration approval of a new molecular test to detect Cystic Fibrosis, a hereditary disease that affects 30,000 Americans. The company filed a 510(k), a type of application that helps companies get their products on the U.S....

Before officially taking over for Jim Barr as the CEO of TDS Telecom, David Wittwer spoke with WTN Media on a range of topics related to the leadership transition. In this first part of a two-part presentation, Wittwer discussed how information technology will help TDS...

Pharma stocks had a mixed performance in 2006, and merger and acquisition activity was the name of the game for the likes of Abbott Labs, 3M, and Monsanto, according to columnist Michael Rosen. In this edition of Yer Biotech Blues, he predicts the M&A trend...